Immatics N.V. (IMTX)

Immatics Revenue

Immatics had revenue of 9.14M EUR in the quarter ending June 30, 2026, with 93.03% growth. This brings the company's total for the last twelve months to 41.70M, down -67.95% year-over-year. In the year 2025, Immatics had annual revenue of 48.27M, down -69.03%. That makes Immatics the 28,321st largest company in the world by revenue and 3,821st in the United States.

• Revenue (ttm): 41.70M EUR
• Revenue Growth: -67.95%
• P/S Ratio: 20.97
• Revenue / Employee: 59,239 EUR
• Employees: 704
• Market Cap: 999.20M USD

Revenue Chart

Chart

Chart

* This company reports financials in EUR.

Revenue by Segment

Chart

• Moderna, United States 37.25M 77.2%
• Bristol-Myers Squibb (BMS), United States 11.02M 22.8%

Fiscal year ended Dec 31, 2025 See the full Immatics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	48.27M	-107.57M	-69.03%
Dec 31, 2024	155.84M	101.84M	188.60%
Dec 31, 2023	54.00M	-118.83M	-68.76%
Dec 31, 2022	172.83M	138.07M	397.17%
Dec 31, 2021	34.76M	3.51M	11.23%
Dec 31, 2020	31.25M	12.80M	69.40%
Dec 31, 2019	18.45M	14.68M	389.36%
Dec 31, 2018	3.77M	-	-

Data Source: Fiscal.ai Last updated: Aug 18, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error